MVision AI
Offers solution for modern cancer radiation therapy treatment through innovative AI technology.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD32—49m (Dealroom.co estimates Mar 2023.)
Company register number 2855115-4
Helsinki Uusimaa (HQ), Helsinki Uusimaa (founding location)
Financials
Estimates*
EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | - | - | <1m | <1m | <1m | 1.5m | 2.5m |
% growth | - | - | - | 569 % | 336 % | 299 % | 68 % |
EBITDA | - | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) | - |
% EBITDA margin | - | - | (2000 %) | (549 %) | (179 %) | (58 %) | - |
Profit | - | (<1m) | (<1m) | (<1m) | (<1m) | (1.1m) | - |
% profit margin | - | - | (2446 %) | (669 %) | (221 %) | (74 %) | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- |
| N/A | - |
* | €620k | Angel | |
$1.7m | Seed | ||
* | €5.4m | Seed | |
Total Funding | CAD11.3m |
Related Content
Recent News about MVision AI
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.